Description

The 5th Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2024) will be held in Kunming, China, during May 28-30, 2024.

Call For Papers

The 5th Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2024)

Websitehttps://www.academicx.org/GECT2024/

DateMay 28-30, 2024

VenueKunming, China

 

The 5th Int'l Conference on Gene Editing and CRISPR Technologies (GECT 2024) will be held in Kunming, China, during May 28-30, 2024. The aim of GECT is to provide a stage for researchers, engineers, academicians as well as industrial professionals from all over the world to present their research results and development activities in Biomedicine, Clinical Application of Gene Editing, CRISPR Systems and CRISPR Technologies, Effective Delivery for Genes in Vitro, Gene Knock In and Genomic Screening, Genome Engineering and DNA repair, Single Base Editing, etc. GECT 2024 will be a valuable and important platform for inspiring international and interdisciplinary exchange at the forefront of CGene Editing and CRISPR Technologies.

 

Attendance Methods

1.Full Paper submission

Submit full paper ( Regular Attendance + Paper Publication + Presentation )

You are invited to submit papers and participate in our academic exchange. One author will be invited to make an oral presentation and the paper will be published by peer-reviewed open access journal.

2.Abstract submission

Submit abstract ( Regular Attendance + Abstract + Presentation )

You are welcome to submit abstract for oral presentation or poster presentation.

3.Regular Attendance ( No Submission Required ) 

You're also welcome to attend our conference (without submitting full paper or abstract)

 

Publication and Presentation

Publication: All the accepted papers will be published by a peer-reviewed open access journal that can ensure the widest dissemination of your published work

Note: 1. If you want to present your research results but do NOT wish to publish a paper, you may simply submit an Abstract.

2.The simple Abstract submission should include the title, contents, keywords, authors names, affiliations and emails. The length is suggested to be controlled within 1 page and no more than 2 pages.

3.The full length of one paper is suggested to be about 15 pages (within the template format with all tables, figures and references). If your paper is over 20 pages, you will be kindly requested to pay for extra pages fees.

4. You will receive the review results within 3-5 working days after submission. If you do not get any notification within the time limit, please contact us as soon as possible.

5. You are welcome to submit papers in Chinese and please contact us for more details.

 

Contact  Us

Email: wsconf5@163.com

Whatsapp: 0086 13264702250

Tel: +86 132 6470 2250 (From Monday to Friday)

QQ: 1349406763

WeChat: 3025797047

Twitter: ConfPriii59781

Official Account: Academic Communications

 

Topics: The conference is soliciting state-of-the-art research papers in the following areas of interest:

Cas Genes and CRISPR Subtypes

Clinical Application of Gene Editing

CRISPR Biology

CRISPR Systems and CRISPR Technologies

CRISPR-Associated Systems

Delivery and specificity of CRISPR-based tools

Different Gene Delivery Systems

Disease Models

Effective Delivery for Genes in Vitro

Gene Drive

Gene Editing Technology and Gene Editing Efficiency

Gene Editing-Based Safety and Ethics

Gene Function

Gene Knock In and Genomic Screening

Gene Therapy

Genetic Vaccines

Genetics and Genomic Medicine

Genome Editing and Genome Regulation

Genome Engineering and DNA repair

In Situ Gene Editing

In Vitro Genetic Depletion

In Vivo Gene Editing

Locus Structure

Molecular Epigenetics

Nano-Therapy

Off-Target Effects

Optimizing Repair of CRISPR-Generated DNA Breaks

Programmable Gene Expression

Regulatory, Safety Aspects of Cell and Gene Therapy

Repeated Sequences

RNA Editing Technology

RNA Guided Nuclease for Genome Modifications

RNAi and Gene Therapy

RNAi based Screening Technologies

Single Base Editing

Spacer Acquisition, Biogenesis, and Interference

Targeted Gene Replacement

Vectors for Gene Therapy

Viral Gene Therapy